Sara Kollack‐Walker

2.9k total citations
45 papers, 2.2k citations indexed

About

Sara Kollack‐Walker is a scholar working on Psychiatry and Mental health, Experimental and Cognitive Psychology and Physiology. According to data from OpenAlex, Sara Kollack‐Walker has authored 45 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Psychiatry and Mental health, 10 papers in Experimental and Cognitive Psychology and 7 papers in Physiology. Recurrent topics in Sara Kollack‐Walker's work include Schizophrenia research and treatment (28 papers), Mental Health Research Topics (10 papers) and Bipolar Disorder and Treatment (8 papers). Sara Kollack‐Walker is often cited by papers focused on Schizophrenia research and treatment (28 papers), Mental Health Research Topics (10 papers) and Bipolar Disorder and Treatment (8 papers). Sara Kollack‐Walker collaborates with scholars based in United States, United Kingdom and Belgium. Sara Kollack‐Walker's co-authors include Sarah Winans Newman, Bruce J. Kinon, Huda Akil, Stanley J. Watson, Virginia L. Stauffer, Haya Ascher‐Svanum, Lei Chen, John M. Kane, Brian A. Millen and Shitij Kapur and has published in prestigious journals such as Journal of Neuroscience, SHILAP Revista de lepidopterología and Annals of the New York Academy of Sciences.

In The Last Decade

Sara Kollack‐Walker

45 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sara Kollack‐Walker United States	22	994	586	558	373	313	45	2.2k
Augusto Pasini Italy	32	1.1k 1.1×	656 1.1×	841 1.5×	868 2.3×	640 2.0×	92	3.2k
Richard Musil Germany	25	864 0.9×	209 0.4×	193 0.3×	260 0.7×	202 0.6×	100	2.0k
Berend Malchow Germany	27	1.3k 1.3×	245 0.4×	359 0.6×	166 0.4×	797 2.5×	86	3.2k
Stefano Porcelli Italy	24	750 0.8×	197 0.3×	337 0.6×	165 0.4×	288 0.9×	72	2.0k
R.M. Post United States	16	1.2k 1.2×	462 0.8×	622 1.1×	435 1.2×	908 2.9×	34	3.4k
Mária Simon Hungary	21	212 0.2×	274 0.5×	435 0.8×	545 1.5×	296 0.9×	56	1.8k
Yun‐Ai Su China	27	411 0.4×	338 0.6×	449 0.8×	479 1.3×	891 2.8×	112	2.4k
Lauri Tuominen Finland	27	341 0.3×	351 0.6×	537 1.0×	183 0.5×	518 1.7×	61	2.0k
Anna Placentino Italy	16	642 0.6×	354 0.6×	363 0.7×	252 0.7×	1.3k 4.1×	26	2.7k
Ali Saffet Gönül Türkiye	24	822 0.8×	132 0.2×	649 1.2×	268 0.7×	843 2.7×	101	2.3k

Countries citing papers authored by Sara Kollack‐Walker

Since Specialization

Citations

This map shows the geographic impact of Sara Kollack‐Walker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara Kollack‐Walker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara Kollack‐Walker more than expected).

Fields of papers citing papers by Sara Kollack‐Walker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sara Kollack‐Walker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara Kollack‐Walker. The network helps show where Sara Kollack‐Walker may publish in the future.

Co-authorship network of co-authors of Sara Kollack‐Walker

This figure shows the co-authorship network connecting the top 25 collaborators of Sara Kollack‐Walker. A scholar is included among the top collaborators of Sara Kollack‐Walker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sara Kollack‐Walker. Sara Kollack‐Walker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Liu‐Seifert, Hong, M. Case, Scott W. Andersen, et al.. (2018). Delayed-Start Analyses in the Phase 3 Solanezumab EXPEDITION3 Study in Mild Alzheimer's Disease. The Journal of Prevention of Alzheimer s Disease. 5(1). 8–14. 9 indexed citations

Chen, Lei, Glenn Phillips, Joseph A. Johnston, et al.. (2011). The relationship, structure and profiles of schizophrenia measurements: a post-hoc analysis of the baseline measures from a randomized clinical trial. BMC Psychiatry. 11(1). 203–203. 9 indexed citations

Kinon, Bruce J., Lu Zhang, Brian A. Millen, et al.. (2011). A Multicenter, Inpatient, Phase 2, Double-Blind, Placebo-Controlled Dose-Ranging Study of LY2140023 Monohydrate in Patients With DSM-IV Schizophrenia. Journal of Clinical Psychopharmacology. 31(3). 349–355. 190 indexed citations

Stauffer, Virginia L., Michael Case, Sara Kollack‐Walker, et al.. (2011). Trajectories of response to treatment with atypical antipsychotic medication in patients with schizophrenia pooled from 6 double-blind, randomized clinical trials. Schizophrenia Research. 130(1-3). 11–19. 31 indexed citations

Peng, Xiaomei, Haya Ascher‐Svanum, D Faries, et al.. (2011). Cost-effectiveness of early responders versus early nonresponders to atypical antipsychotic therapy. SHILAP Revista de lepidopterología. 3. 79–79. 11 indexed citations

Stauffer, Virginia L., Michael Case, Bruce J. Kinon, et al.. (2010). Early response to antipsychotic therapy as a clinical marker of subsequent response in the treatment of patients with first-episode psychosis. Psychiatry Research. 187(1-2). 42–48. 52 indexed citations

Stauffer, Virginia L., Jennifer Gatz, Sara Kollack‐Walker, et al.. (2010). Impact of race on efficacy and safety during treatment with olanzapine in schizophrenia, schizophreniform or schizoaffective disorder. BMC Psychiatry. 10(1). 89–89. 20 indexed citations

Kinon, Bruce J., Lei Chen, Virginia L. Stauffer, et al.. (2010). Early Onset of Antipsychotic Action in Schizophrenia. Journal of Clinical Psychopharmacology. 30(3). 286–289. 11 indexed citations

Case, M., Virginia L. Stauffer, Haya Ascher‐Svanum, et al.. (2010). The heterogeneity of antipsychotic response in the treatment of schizophrenia. Psychological Medicine. 41(6). 1291–1300. 58 indexed citations

10.

Lipkovich, Ilya, Walter Deberdt, John G. Csernansky, et al.. (2009). Relationships among neurocognition, symptoms and functioning in patients with schizophrenia: a path-analytic approach for associations at baseline and following 24 weeks of antipsychotic drug therapy. BMC Psychiatry. 9(1). 44–44. 57 indexed citations

11.

Kinon, Bruce J., Lei Chen, Haya Ascher‐Svanum, et al.. (2009). Early Response to Antipsychotic Drug Therapy as a Clinical Marker of Subsequent Response in the Treatment of Schizophrenia. Neuropsychopharmacology. 35(2). 581–590. 146 indexed citations

12.

Lipkovich, Ilya, Walter Deberdt, John G. Csernansky, et al.. (2009). Defining “good” and “poor” outcomes in patients with schizophrenia or schizoaffective disorder: A multidimensional data-driven approach. Psychiatry Research. 170(2-3). 161–167. 27 indexed citations

13.

Chen, Lei, Haya Ascher‐Svanum, Virginia L. Stauffer, et al.. (2009). Optimal thresholds of early response to atypical antipsychotics: Application of signal detection methods. Schizophrenia Research. 113(1). 34–40. 20 indexed citations

14.

Kinon, Bruce J., Lichang Chen, Haya Ascher‐Svanum, et al.. (2008). Predicting response to atypical antipsychotics based on early response in the treatment of schizophrenia☆. Schizophrenia Research. 102(1-3). 230–240. 123 indexed citations

15.

Kinon, Bruce J., et al.. (2008). Olanzapine Versus Aripiprazole for the Treatment of Agitation in Acutely Ill Patients With Schizophrenia. Journal of Clinical Psychopharmacology. 28(6). 601–607. 44 indexed citations

16.

Kinon, Bruce J., Angela Hill, Hong Liu, & Sara Kollack‐Walker. (2003). Olanzapine orally disintegrating tablets in the treatment of acutely ill non-compliant patients with schizophrenia. The International Journal of Neuropsychopharmacology. 6(2). 97–102. 60 indexed citations

17.

Kollack‐Walker, Sara, et al.. (2003). Olanzapine improves tardive dyskinesia in patients with schizophrenia. Schizophrenia Research. 60(1). 359–359. 3 indexed citations

18.

Kabbaj, Mohamed, Christine Norton, Sara Kollack‐Walker, et al.. (2001). Social defeat alters the acquisition of cocaine self-administration in rats: role of individual differences in cocaine-taking behavior. Psychopharmacology. 158(4). 382–387. 119 indexed citations

19.

Kollack‐Walker, Sara & Sarah Winans Newman. (1997). Mating-induced expression of c-fos in the male Syrian hamster brain: Role of experience, pheromones, and ejaculations. Journal of Neurobiology. 32(5). 481–501. 120 indexed citations

20.

Kollack‐Walker, Sara & Sarah Winans Newman. (1995). Mating and agonistic behavior produce different patterns of Fos immunolabeling in the male Syrian hamster brain. Neuroscience. 66(3). 721–736. 259 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact